According to Reuters, the World Health Organization (WHO) reported on Wednesday that, in addition to the one already approved by Pfizer and BioNTech, three COVID-19 vaccines were in the late stages of the analysis for future emergency use listings.
An internal WHO document seen by Reuters offers timelines for potential vaccine approvals from the agency, suggesting that in coming weeks or months, shots from Moderna, AstraZeneca, and China’s Sinopharm and Sinovac could receive the emergency go-ahead.
“We have one vaccine so far listed. We have 3 more in the final phase to be assessed for listing, we have 2 more still submitting…In total, we have 13,” Mariangela Simao, WHO assistant director-general for access to medicines, vaccines, and pharmaceuticals.
No deaths related to the Pfizer vaccine or any other vaccine is known to the WHO, she added.
Source: Reuters
